As more GLP-1 prescriptions are written to manage not just diabetes and cardiovascular disease but also obesity, a key question emerges: What is the role of patient engagement and chronic disease management when prescribing these drugs
GLP-1 drugs may reshape brain's dopamine reward system Beyond weight loss, research is pointing to broader effects on the brain
Decrease in lung inflammation is why GLP-1 meds work for asthma patients In a fun twist, that is beyond the scope of this post but worth mentioning, in the rodent models lacking GLP-1R in the brain were given tirzepatide, a GLP-1 & GIP agonist, then some of the anti-inflammatory benefits returned, suggesting GIP has an anti-inflammatory role as well
And the clinical outcomes at matching timepoints reveal a gap that keeps widening with every new dataset published
Within 13 days a clinician will review your medical history and contact you with your personalized plan
Safe Ways to Discontinue GLP-1 Therapy Planning and communication with your healthcare team are essential components of safely discontinuing GLP-1 receptor agonist therapy